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A comprehensive analysis of e-CAS 
cell line reveals they are mouse 
macrophages
Elizabeth Evans1,2, Romain Paillot1 & María Rocío López-Álvarez  1
The 3Rs principles (Replacement, Reduction and Refinement) are focused on finding alternatives to 
the use of animals in research. In this regard, cell lines are popular and useful tools for the replacement 
of primary cells in in vitro studies. However, around 15–30% of cell lines used in research have been 
misidentified or cross-contaminated generating concerns about the results obtained from experiments 
that use them. Here we described how old aliquots of an equine macrophage cell line (e-CAS) stored at 
the Animal Health Trust did not contain equine cells but macrophages of murine origin (m-CAS).
Scientists are looking for non-sentient alternatives to support the Replacement, Reduction and Refinement (3Rs) 
principles and minimise the use of animal’s samples in research (https://www.nc3rs.org.uk/the-3rs). In this sense, 
cell lines are the most cost effective and popular replacement for primary cells thanks to their unlimited life span 
and ability to grow indefinitely without compromising reliable results. However, the use of cell lines comes with 
associated challenges like genomic variations and alteration of phenotypic characteristics of the cells over time1–3. 
Also, the possibility of misidentification through contamination by other cells cannot be discarded and could lead 
to the use of the wrong cell line4. Several studies have shown that around 15–30% of cell lines used in research 
have been misidentified5,6, creating problems and concerns about the results obtained from them. Therefore, it is 
essential to appropriately characterise cell lines before their use7–9.
As scientists working in equine immunology, our objective is to obtain reliable and relevant results whilst 
minimising the use of samples obtained from animals. Our current research is focused on the innate immune 
response to Streptococcus equi (S. equi), a horse restricted pathogen, and how the equine innate immune cells, 
essentially equine macrophages and equine neutrophils, respond to S. equi infection in vitro.
The availability of equine cell lines in the market is quite limited. The ATCC only provides one horse fibroblast 
cell line (ATCC® CCL-57™); it also offers horse tissue of unknown origin (ATCC® CRL-6583™) for which they 
are not responsible for its production and characterisation. Therefore, the use of equine cell lines to meet the 3Rs 
principles is limited and relies on aliquots kindly provided by other scientists.
e-CAS is an equine macrophage cell line developed to study equine-specific pathogenic pathways and thera-
peutic modulation of macrophage response to defined stimuli10. As equine macrophages, this cell line is ideal for 
evaluating the innate immune response to S. equi, and aliquots of e-CAS cells have been available at the Animal 
Health Trust (AHT) since 2003. Our aim was to detect variations in the expression of Toll-Like Receptors (TLR) 
in these cells by reverse transcriptase-quantitative PCR (RT-qPCR) after their stimulation with different mitogens 
or S. equi strains.
Here we describe how during the development of a PCR reaction specific for equine TLR6 we realised that the 
aliquots of e-CAS cells at the AHT did not contain an equine macrophage cell line, but macrophages of murine 
origin.
Results
The specificity of the newly developed reactions for TLR1 and TLR6 was determined by PCR-SSP in DNA samples 
obtained from e-CAS and eqT8888 cell lines. Previously developed TLR2 and TLR4 reactions (Table 1)11 were also 
tested alongside. As shown in Fig. 1, amplification of e-CAS DNA was only detected for TLR6 (Fig. 1A). DNA 
from eqT8888 cells showed a clear band corresponding to the expected size for each of the reactions considered 
(Fig. 1B). The same reactions were also carried out using archived DNA samples from pony P1 (Supplementary 
Fig. S1), obtaining specific amplification for all TLR reactions.
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Sequencing of the TLR6 gene from e-CAS, eqT8888, P1 and P2 revealed up to 10 single nucleotide poly-
morphisms (SNPs) in the sequence obtained from e-CAS cells when compared with the results obtained from 
eqT8888 cells or archived DNA from ponies (Fig. 2; Supplementary Fig. S2). Sequences obtained from eqT8888, 
P1 and P2 DNA samples matched TLR6 from Equus caballus when compared to those available in the NCBI 
database using Basic Local Alignment Search Tool (BLAST). However, the sequence obtained from e-CAS DNA 
sample shared a 99% identity with TLR6 from Mus musculus (Fig. 3).
Short tandem repeats (STRs) are short DNA sequences of normally 2–6 bp in length that are tandemly 
repeated and can be easily amplified by PCR. Currently, STR profiling is the standard tool for cross-contamination 
and authentication of human and cell lines from other species12,13. In order to confirm the results obtained from 
the TLR6 sequencing, an equine DNA profiling by STRs analysis was performed in DNA samples from e-CAS, 
eqT8888 and P1. Peaks for samples from eqT8888 and P1 could be detected, analysed and alleles were assigned to 
each marker according to the assignment on International Society of Animal Genetics (ISAG) horse comparison 
test (Table 2). However, no results were obtained from e-CAS cells.
Considering the results obtained for eCAS cells from the BLAST alignment and the lack of amplification dur-
ing the equine DNA profiling, an aliquot of e-CAS DNA was analysed by Dr Georges Wigger (Microsynth AG, 
Switzerland) using the mouse DNA profiling STR test described by Almeida et al. in 201413. STRs in 9 murine loci 
Target Forward (5′-3′) Reverse (5′-3′) Amplicon size
TLR1 TCCACATGCTTTGCCCATCT CCAGCTTAGTCAATGTTCCACA 108
TLR2 GGCACTGGACCAGATCCTGAT TGGCATTCAGAGACCGAGAGA 111
TLR4 ATGCCCGTGCTGGGTTTTA ACTTTTTGCAGCCAGCAAGAA 151
TLR6 TGTTCAGAGTGAGTGGTGCC CCTCTGTGTCATGAGAGCCC 157
Table 1. Primers used to detect equine TLRs.
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Figure 1. PCR reactions for equine TLRs. Reactions performed with (A), DNA sample obtained from e-CAS 
cells and (B), DNA sample obtained from eqT8888 cells. L: Ladder. The picture has been cropped for clarity and 
conciseness. A picture of the full-length gel is presented in Supplementary Fig. S1.
www.nature.com/scientificreports/
3Scientific REPORtS |  (2018) 8:8237  | DOI:10.1038/s41598-018-26512-3
were positively identified (Fig. 4) in eCAS DNA. The different chromosomal locations and fragment lengths are 
shown in Table 3. No trace of contamination with another mouse or human cell lines was detected.
Discussion
When we conceived the project, e-CAS cells were considered as a replacement for primary macrophages obtained 
from ponies in order to determine variations in the expression of TLRs in response to different stimulatory con-
ditions. e-CAS cells were derived from bone marrow of two 10-year-old horses to generate an equine macrophage 
Figure 2. TLR6 sequences alignment. Results obtained from sequencing of e-CAS, eqT8888, P1 and P2 DNA 
samples using the primers forward (top) and reverse (bottom) primers for the TLR6 reaction. SNPs are in bold.
Figure 3. e-CAS and mouse TLR6 sequences alignment. Results obtained from sequencing of e-CAS DNA 
samples were compared to the sequences available in the NCBI using BLAST. The figure shows the alignment of 
TLR6 sequences from e-CAS cells and mouse.
Marker
Alleles*
eqT8888 Pony Marker eqT8888 Pony
AHT4 H H HMS6 KM LP
AHT5 KN JO HMS7 MN KO
ASB2 R KQ HTG4 K M
ASB17 GO OR HTG6 GJ O
ASB23 KS JU HTG7 N KO
CA425 N J HTG10 MO O
HMS1 IJ J LEX3 H K
HMS2 L K LEX33 M KL
HMS3 IO MP VHL20 IN MO
Table 2. Equine DNA profile of eqT8888 cell line and a control pony. *According to the assignment on 
International Society of Animal Genetics (ISAG) horse comparison test.
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cell line suitable for the study of equine-specific pathogenic pathways of macrophage response to defined stimuli10 
and, therefore, the ideal candidates for our work. However, DNA samples isolated from e-CAS cells stored at the 
AHT did not show amplification for any of the equine TLR reactions considered in our study except for equine 
TLR6 (Fig. 1A). In contrast, specific amplification was observed for each reaction when DNA from eqT8888 cells 
(Fig. 1B) or samples from control ponies (Supplementary Fig. S1) were used. The PCR reactions were designed 
for equine TLRs avoiding any known polymorphism in these genes. Amplicons were observed in 3 out of the 4 
samples used, suggesting that the lack of amplification was not a technical problem of the PCR but something 
related to the DNA sample obtained from e-CAS cells.
The products amplified in the TLR6 reactions for each sample were sequenced and, after aligning the 
sequences, it could be observed that e-CAS sample differed from eqT8888, P1 and P2 samples. Results from their 
comparison to sequences in the NCBI database showed that sequences obtained from eqT8888, P1 and P2 DNA 
samples matched TLR6 Equus caballus, whilst the sequence obtained from e-CAS cells shared a 99% identity with 
TLR6 from Mus musculus (Fig. 3). These results were further confirmed by DNA profiling (Tables 2 and 3; Fig. 4).
Figure 4. Mouse DNA profiling of e-CAS cells. The figure shows the electropherogram obtained from the DNA 
profiling of e-CAS cells. 9 murine markers were positively identified in the assay. Possible contamination with 
another mouse or human cell line was discarded.
Locus Chromosomal location Fragment lengths
18-3 Chr18 162
4-2 Chr04 248/252
6-7 Chr06 335
9-2 Chr09 221/225
15-3 Chr15 205
6-4 Chr06 301
12-1 Chr12 231/235
5-5 Chr05 339
X-1 X 401
Human D8/D4 — —
Table 3. Mouse DNA profile of e-CAS cell line. *DNA profile performed by Microsynth AG using highly-
polymorphic short tandem repeat loci (STR) published by Almeida et al.13.
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Cross-contamination between cell lines is quite frequent14,15 and could explain the non-equine nature of 
e-CAS cells. During the differentiation and development of e-CAS cells, their expression of CD14 was compared 
with a mouse macrophage cell line (RAW264.7) to clearly establish the identity of e-CAS cells as macrophages10. 
It could be plausible that the fitter and faster growing murine cell line took over the cell culture replacing the 
original equine macrophages. However, the DNA profile obtained from e-CAS does not exactly match the one 
described for RAW264.7 in 2014 by Almeida et al.13, discrepancy that could be explained by alterations in their 
fingerprint profile with prolonged culture, as has been described for other cell lines2.
In 2007, Steinbach et al. published a study in which they evaluated the cross-reactivity of anti-human leu-
kocyte monoclonal antibodies using e-CAS and eqT8888 cell lines16. The authors concluded that e-CAS cells 
represented an early stage of differentiation in which the characteristic macrophage surface antigens could not 
be detected. Nonetheless, they were clearly positive when they used an anti-mouse CD11b antibody, result that 
could also support the fact that the e-CAS cells used in their study were of murine origin. We have demonstrated 
that e-CAS cell express CD14 on their surface (Supplementary Fig. S3).
To our knowledge, e-CAS cells have been used in two other publications17,18. Wijnker et al. showed that the 
TNF-α release in both e-CAS cells and the human cell line U937 was similarly affected by the presence of a 
TNF-α converting enzyme (TACE) inhibitor17. Lankveld et al. investigated the effect of ketamine on TNF-α 
and IL-6 release and observed that ketamine suppress LPS-induced TNF-α concentration in both e-CAS and 
U937 cells in a dose dependent manner and the effect of ketamine was also evident on the concentration of IL-6 
released by e-CAS cells18. The assays used by both groups were developed for their use in different species; they 
were not specific methods to measure equine cytokines19,20. Three other publications21–23 have referenced Werners 
et al.10, but in all cases the citation was related to the method used during the development and differentiation of 
e-CAS cells, and was not associated with the characteristics of these cells as equine macrophages. To our knowl-
edge, there is no other publication in which e-CAS cells have been used in equine-specific experiments.
In summary, this work shows that the aliquots of e-CAS cells stored at the AHT are of murine origin rather 
than equine macrophages. However, this established identity was only possible after performing molecular assays 
that are specific for the equine species.
In conclusion, the data presented here highlight the importance of cell line authentication prior to their use 
in research.
Materials and Methods
Cell lines. Two cell lines were used in this study. e-CAS cell line is described as equine macrophages derived 
from bone marrow of two 10-year-old horses10; eqT8888 are equine cells of lymphoid origin but not completely 
characterised24.
DNA samples. DNA from e-CAS and eqT8888 cell lines was extracted using a QIAamp DNA minikit (QIAGEN) 
following manufacturer’s instructions. Archived DNA aliquots from two ponies (P1 and P2) were used as controls.
Reactions for equine TLRs. Previously published gene specific oligonucleotide primers were used to amplify 
equine TLR2 and TLR4 (Table 1)11. Specific oligonucleotide primer pairs for equine TLR1 and TLR6 were designed 
using Primer3 software25,26, ensuring the primers completely match all the sequences available in the National Centre 
for Biotechnology Information (NCBI) database and did not fall within polymorphic areas of any of the genes. PCR 
was performed using 2 μM of each primer, 1.5 µM of MgCl2, 200 µM dNTP, 10 ng DNA template and 0.25 µl Hotstar 
taq polymerase. Cycling conditions were: enzyme activation at 95 °C for 15 min, 35 cycles of 95 °C for 30 s, 55 °C for 
30 s and 72 °C for 1 min, and a final extension at 72 °C for 10 min. After the PCR process, amplified DNA fragments 
were resolved at 115 V for 45 minutes using a 1.5% agarose gel stained with GelRed (Biotium).
TLR6 Sequencing. Specific amplified products from the TLR6 PCR-SSP reaction were used for sequencing. 
The amplicons were purified using a Monarch® PCR & DNA Cleanup Kit (New England Biolabs) following 
manufacturer’s instructions. One reaction for each primer (forward and reverse) was prepared in an Axygen 96 
well plate. Each reaction contained 5 µl sequencing buffer, 5 µl water, 1 µl BigDye Terminator v3.1 (Thermofisher), 
1 µM forward or reverse primers and 2.5 µl DNA. Cycling conditions were: 25 cycles at 96 °C for 15 s, 50 °C for 
10 s and 60 °C for 2 min, followed by 10 °C indefinitely. The sequencing PCR reactions were purified by ethanol 
precipitation. 10 µl Hi-di was then added to each well and samples were denatured in a PCR machine at 95 °C for 
1 min. The sequencing was performed on the ABI 3130XL genetic analyser (Applied Biosystems). Archived DNA 
samples from two Welsh Mountain ponies (P1, P2) were used as equine controls.
Results were analysed using Chromas (Technelysium) and aligned using Mega software27.
DNA profiling. A short tandem repeat (STR) analysis was performed by the Equine Genetic Service at the 
AHT, an ISAG (International Society for Animal Genetics) registered laboratory. Genomic DNA samples from 
eCAS, eqT8888 and pony P1 were tested. The equine STR marker panel consisted of alleles at 18 different micro-
satellite loci: AHT4, AHT5, ASB2, ASB17, ASB23, CA425, HMS1, HMS2, HMS3, HMS6, HMS7, HTG4, HTG6, 
HTG7, HTG10, LEX3, LEX33 and VHL20. PCR were performed in a G-Storm GS4 Multi Block Thermal Cycler 
(G-storm). PCR products were separated in a capillary electrophoresis system on the 3130XL Genetic Analyser 
(Applied Biosystems). The GeneScan-500 LIZ Size Standard was used in each sample run for an application of 
automated DNA fragments analysis with five fluorescent dyes. Analysis of DNA profiles for 18 STR loci was con-
ducted using GeneMapper 4.0 software (Applied Biosystems).
e-CAS cell line DNA profiling was performed by Mycrosynth AG (Switzerland) following the STR analysis 
developed by Almeida et al.13 for the authentication of mouse cell lines.
Data availability. No datasets were generated or analysed during the current study.
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